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Abstract 
Polycystic Ovarian Syndrome (PCOS) is a common and reversible 
endocrine disorder affecting as many as 3.5-5.0 million women in the United 
States and has serious implications for women from adolescence to beyond 
menopause. PCOS is characterized by oligo-amenorrhea, anovulation, clinical, 
biochemical signs of hyperandrogenism, or polycystic ovaries the majority which 
can be identified in adolescence (ages 13-18). Although the majority of these 
reproductive and metabolic consequences can be identified in adolescence, 
diagnosis of PCOS for subsequent early intervention is still not taking place as 
many women are not being diagnosed until their reproductive years often after 
seeking the cause of their infertility. No literature could be found on barriers that 
contribute to the failure of early diagnosis of PCOS in adolescence. There is a gap 
in the literature investigating the barriers of diagnosing PCOS in adolescents. This 
was a descriptive study done to: (1) identify factors practitioners consider when 
determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) identify 
barriers to early diagnosis of PCOS in adolescents (ages 13-18) among 
practitioners. Barriers to diagnose PCOS in adolescents will be explored using the 
Polycystic Ovarian Syndrome in Adolescence questionnaire which was developed 
by the researcher. The  Qualtrics Survey Program was used to submit an 
electronic survey. Barriers for diagnosing PCOS in adolescents were 
acknowledged and identified by participants in this study. Because this data was 
mainly derived from a single group within the practice area, certified nurse 
practitioners, it is unclear whether these findings can be generalized to other 
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practice areas within the healthcare system. Future investigations should examine 
whether these barriers do exist amongst other practice areas, can yield enough 
results to be generalized, and focus on designing interventions to improve the 
diagnosis of PCOS in adolescents. 
Keywords: barriers, Polycystic Ovarian Syndrome (PCOS), adolescents 
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Chapter 1: Introduction and Literature Review 
Introduction 
Polycystic Ovarian Syndrome (PCOS) is a common and reversible endocrine 
disorder affecting as many as 3.5-5.0 million women in the United States and has serious 
implications for women from adolescence to beyond menopause (Barron, 2004). PCOS is 
characterized by oligo-amenorrhea or anovulation, clinical or biochemical signs of 
hyperandrogenism, or polycystic ovaries the majority which can be identified in 
adolescence ages 13-18 (Bates & Legro, 2012; Glueck, Dharashivkar, Wang, Zhu, 
Gartside, Tracy, & Sieve, 2005; Nicholson, Rolland, Broom, & Love, 2010).  PCOS has 
proven long-term reproductive and metabolic consequences such as infertility, obesity, 
diabetes, hypertension, heart disease, and several gynecological cancers (Bates & Legro, 
2012; Barron, 2004; Glueck, et al., 2005; Nicholson, et al., 2010; West, S.,  Lashen, H., 
Bloigu, A., Franks, S.,  Puukka, K., Ruokonen, A., Järvelin, M., Tapanainen, J., Morin-
Papunen, L., (2014).  Although the majority of these reproductive and metabolic 
consequences can be identified in adolescence, diagnosis of PCOS for subsequent early 
intervention is still not taking place as many women are not being diagnosed until their 
reproductive years often after seeking the cause of their infertility (Makarov, 2011; 
Meurer, Kroll, & Jamieson, 2006).  
Symptoms commonly experienced by girls in their teenage years, such as 
irregular menses, acne, and weight gain are also part of normal physiologic pubertal 
changes (Hassan & Gordon, 2007).  However, PCOS should not be overlooked as an 
underlying cause. PCOS is the source of 51% of the bleeding irregularities seen the most 
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common cause of hormonal disturbances triggering acne and hirsutism, and is seen in 
27% of obese adolescents (Dramusic, Goh, Rajan, Wong, & Ratnam, 1997; West, et al., 
2014).The diagnosis of PCOS is made by exclusion, where all other causes of symptoms 
are ruled out by diagnostic procedures and labs (Rosenfield, 2008). Due to the significant 
correlation between symptoms commonly experienced by girls in their teenage years and 
PCOS, it is critical healthcare providers consider an endocrine evaluation to diagnose 
ovulatory disorders such as PCOS (Barron, 2004; Rosenfield, 2008) when such 
symptoms exist in an adolescent.  No literature could be found on barriers contributing to 
the failure of early diagnosis of PCOS in adolescence. Therefore, the purpose of this 
study is to identify barriers to early diagnosis of PCOS in adolescents ages 13-18 among 
practitioners.  
Research Questions  
(1) What factors do practitioners consider when determining the diagnosis of PCOS? 
(2) What are the barriers to early diagnosis of PCOS in adolescence among 
practitioners? 
Literature Review  
Polycystic Ovarian Syndrome (PCOS) is the most common endocrine condition 
affecting young women where anovulation, hyperandrogenism, obesity, diabetes, and 
infertility are often seen (Barron, 2004; Bates & Legro, 2012; Glueck, et al., 2005; 
Nicholson, et al., 2010;West, et al., 2014 ). Typical clinical manifestations include 
hirsutism, acne, and alopecia (DuRant & Leslie, 2007). The diagnosis for PCOS in 
adolescence and women is based on the revised 2003 Rotterdam European Society of 
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Human Reproduction and Embryology/American Society for Reproductive Medicine 
(ESHRE/ASRM) consensus criteria (Rotterdam, 2004) as well as the National Institute of 
Health’s (NIH) 1990 consensus criteria (Bates & Legro, 2012; Glueck, et al., 2005; 
Nicholson, et al., 2010). Studies done by Barron (2004); Glueck et al. (2005); Makarov, 
(2011); Meurer, Kroll, & Jamieson, (2006) conclude diagnosis and intervention in 
adolescent years are critical in the treatment of this reversible endocrine disorder. 
Although the literature review revealed symptoms of PCOS as well as metabolic 
consequences are seen in adolescent years, diagnosis is not taking place until women are 
in their reproductive years often after seeking the cause of their infertility (Makarov, 
2011; Meurer, Kroll, & Jamieson, 2006).  
Overview of Polycystic Ovary Syndrome (PCOS) 
PCOS was first diagnosed by American gynecologists Irving F. Stein and Michael 
L. Leventhal in 1935 after extensive research on seven women with amenorrhea, 
hirsutism, and bilateral polycystic ovaries, had been completed (Ehrmann, 2005; Hoe and 
Dokras, 2011).  Although descriptions of the syndrome can be found in Italian literature 
dating back to 1721, it was the presentation of Stein and Levanthal’s study of these seven 
women to the Central Association of Obstetricians and Gynecologists in 1935 gaining the 
syndrome a more comprehensive description. Then PCOS was described as women who 
had amenorrhea, hirsutism, and enlarged ovaries with multiple small cysts and thickened 
tunica (Farquhar, 2007). The current description of PCOS is: the most common endocrine 
condition with symptoms such as oligomenorrhea, anovulation, hyperandrogenism, and 
polycystic ovaries (Barron, 2004; Bates & Legro, 2012; Glueck, et al., 2005; Nicholson, 
et al., 2010). 
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Currently, PCOS is the most common endocrine condition affecting young 
women where anovulation, hyperandrogenism, obesity, diabetes, and infertility are often 
seen (Barron, 2004; Bates & Legro, 2012; Glueck, et al., 2005; Nicholson, et al., 2010; 
West, et al., 2014). Oligomenorrhea and anovulation are symptoms seen in 89% of 
adolescents as a normal physiological process of puberty, however 51% of these cases are 
due to PCOS (Makarov, 2011; Meurer, Kroll, & Jamieson, 2006; West, et al., 2014). 
Oligomenorrhea is defined as missing over four menstrual cycles a year after the onset of 
a woman’s menses. Anovulation is a condition where ovaries do not release an oocyte; 
during a menstrual cycle. If oligomenorhea or anovulation persists for 2 years after the 
onset of menses, PCOS should be considered (Hart, 2007; West, et al., 2014). 
Hyperandrogenism is the most consistent diagnostic feature of PCOS; it is 
elevation of serum androgen levels or male hormones. Adolescents who have irregular 
menses have higher levels of plasma androgen than those with regular cycles (Venturoli, 
Porcu, Fabbri, Paradisi & Ruggeri, 1986; West, et al., 2014). Clinical manifestations of 
hyperandrogenism are acne, alopecia or male pattern balding, unwanted hair growth or 
hirsutism, and seborrhea (Azziz, Woods, Reyna, Key, Knochenhauer & Yildiz, 2004). 
Polycystic ovaries are the result of a follicular arrest in which many small follicles 
develop in the ovaries but are not developed to an ovulatory size, and fail to ovulate. 
Although the term “cyst” can be an alarming term, these are not pathological cysts. They 
are immature follicles not developing to ovulatory size.  A polycystic ovary is one in 
which 12 or more follicles measuring 2-9 mm in diameter or increased ovarian volumes 
are present, as defined by transvaginal ultrasound (Balen, 2003). Polycystic ovaries are 
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also a normal physiological variant of adolescents (Rosenfeld, 2011). Therefore, the use 
of a transvaginal ultrasound in adolescents may not confirm PCOS.  
Golden & Carlson’s position, “it appears to be a combination of defects in insulin 
resistance and ovarian and/or adrenal hypersensitivity (Golden & Carlson, 2008, p. 171). 
Women who have PCOS often have first generation relatives who also suffer from the 
disorder (Golden & Carlson, 2008). Hyperandrogenism, the main underlying problem 
identified in PCOS is a hormonal imbalance in which male hormones females make are 
higher than normal affecting the normal physiological process of ovulation; the 
development of follicles, and subsequent release of eggs. Hyperinsulinemia may also 
play a significant role in which women with PCOS have too much insulin in their bodies. 
Hyperinsulinemia affects the production of androgens as well. Insulin increases 
production of androgens, and high levels of androgens lead to acne, hirsutism, weight 
gain, issues with ovulation (Glueck, et al., 2005; Nicholson, et al., 2010). 
Consequences of PCOS 
PCOS produces a negative impact on quality of life and health status. A 
systematic review of 18 studies on PCOS concluded there were detrimental effects of 
PCOS on quality of life (Jones, Hall, Ledger & Balen, 2008). Trent, Austin, Rich and 
Gordon (2005) examined the effect of body mass index on quality of life disturbances in 
adolescent girls (aged 13-22) with PCOS (demonstrated by hyperandrogenism and 
menstrual irregularity) in their cross-sectional study. Researchers compared disruption in 
health-related quality of life (HRQL) between adolescent girls with PCOS and their 
healthy peers.  It was found adolescent girls with polycystic ovary syndrome (PCOS) 
have significant disruption in health-related quality of life (HRQL) compared to their 
6 
 
peers. Particularly, adolescent girls with PCOS had lower scores on health perception, 
physical functioning, and family activities. Similar findings have been reported in a 
qualitative study conducted by (Jones et.al., 2011). Jones and colleagues (2011) explored 
quality of life among adolescents (ages 17-21) with PCOS. Results from their semi-
structure interviews revealed the negative impact PCOS had on their quality of life with 
emotional, social functioning being most affected. In addition, Trent et al. (2005) found a 
negative correlation between PCOS and insulin resistance. More than 50% of women 
with this disorder are obese, which further exacerbates difficulties with insulin resistance 
and increases risk for type 2 diabetes mellitus (Salehi, Bravo-Vera, Sheikh, Gouller, 
Poretsky, 2004). 
Obesity and insulin resistance are common components of PCOS, and may trigger 
the onset in genetically predisposed individuals (Arslanian & Witchel, 2002). A study 
Warren-Ulanch and Arslanian, (2006) found the majority of adolescents are either 
overweight or obese.  However, insulin resistance is often seen in non-obese adolescents 
with PCOS as well. Adolescents with PCOS generally have significant abdominal fat 
known as android distribution even if they are not obese, as well as signs of insulin 
resistance such as acanthosis nigricans (Hoe and Dokras, 2011). Abdominal obesity is 
also associated with greater metabolic dysfunction in adolescents with PCOS (Bruni, Dei, 
Nannini, Balzi & Nuvolone, 2010). Coviello, Legro, and Dunaif (2006) reported an 
association between PCOS and metabolic syndrome independent of body mass index 
(BMI); obese adolescents with PCOS had a greater prevalence of metabolic syndrome 
than obese adolescents without PCOS. Adolescents with PCOS have decreased insulin 
sensitivity compared with Body Mass Index-matched controls (Apter et al., 1995).  
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PCOS also produces an impact on the aspect of mental health.  Major clinical 
manifestations of PCOS present during adolescents. Hirsutism, acne, and obesity can 
affect self-image, self-esteem, and quality of life of young women (Ching, Burke, & 
Stuckey, 2007). Depressive disorders are seen in 60% of women with PCOS 
(Bhattacharya & Jha, 2010). Eating disorders are seen in 35% of women with hirsutism 
(Morgan, Scholtz,  Lacey & Conway, 2008). Androgens stimulate appetite, so high levels 
of these hormones can account for the inappropriate eating behaviors women with PCOS 
often face (Naessén, Carlström, Garoff, Glant & Hirschberg, 2006; West, et al., 2014). 
Reproductive and metabolic issues are some of the major consequences of PCOS.  
PCOS is characterized by oligo-menorrhea, chronic anovulation, infertility, polycystic 
ovaries, and clinical and biochemical hyperandrogenism. Approximately 50% of women 
with PCOS also have obesity which exacerbates heritable insulin resistance, promoting 
hyperinsulinemia (Glueck et al., 2005). Obesity promotes a sequel of metabolic effects 
such as diabetes, cardiovascular disease, hypertension, and several cancers affecting the 
female reproductive system (Glueck et al., 2005; Nicholson, et al., 2010). With effective 
management, women may be able to conceive earlier and experience fewer adverse 
obstetrical outcomes, as well as lowering the risk of chronic diseases later in life (Barron, 
2004). 
Diagnosis of Polycystic Ovarian Syndrome 
Diagnostic Criteria. Diagnosis of PCOS is based on the revised 2003 Rotterdam 
ESHRE/ASRM consensus criteria (Rotterdam, 2004) in which two of the three criteria 
are required for diagnosis: oligo-amenorrhea or anovulation, clinical or biochemical signs 
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of hyperandrogenism, or polycystic ovaries. National Institute of Health’s (NIH) 
consensus criteria(1990) is based on symptoms of chronic anovulation, clinical or 
biochemical signs of hyperandrogenism; while excluding all other etiologies (Glueck, et 
al., 2005; Nicholson, et al., 2010). The Rotterdam ESHRE/ASRM and NIH criteria can 
be used to diagnose PCOS in adults but there are no specific criteria to diagnose PCOS in 
adolescent girls (Drosdzol-Cop, A., Sidło-Stawowy, A., Sajdak, D., Skrzypulec-Plinta, 
V., 2014).  
 Since PCOS is a diagnosis of exclusion tools/test are often used to aid in the 
diagnosis of PCOS (Glueck, et al., 2005; Nicholson, et al., 2010).  Diabetic screening is 
important due to the coorelation of and metabolic consequences of hyperinsulinemia in 
PCOS; insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus 
(Stankiewicz & Norman, 2006). Androgen analysis can help rule out other causes of 
hyperandrogenism ruling out an androgen-secreting tumor, congenital adrenal 
hyperplasia, or Cushing’s stigmata (Stankiewicz & Norman, 2006). Menstrual calendars 
can help distinguish oligomenorrhea and anovulation (Hart, 2007; Talib & Coupey, 2012; 
West, et al., 2014).   
Challenges of Early Diagnosis.  Drosdzol-Cop et. al., (2014); Golden and Carlson 
(2010); Weiss and Bulmer (2010) contend there are no current diagnostic guidelines for 
adolescents with PCOS; therefore, the basis of diagnosis is on hyperandrogenism, oligo-
amenorrhea or anovulation, and polycystic ovaries (West, et al., 2014).  Due to lack of 
diagnostic guidelines, diagnosis is often problematic because symptoms commonly 
experienced by girls in their teenage years, such as irregular menses, acne, and weight 
gain are also part of normal physiologic pubertal changes (Hassan & Gordon, 2007). For 
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this age group, the most robust diagnostic criterion for PCOS is clinical or biological 
expression of hyperandrogenism (Drosdzol-Cop et. al., 2014; Hassan & Gordon, 2007; 
West, et al., 2014).  The predominant manifestation of excess androgens is hirsutism, 
affecting 50-76% of adolescents and women (Lee & Zane, 2007; West, et al., 2014). 
While the use of the Rotterdam ESHRE/ASRM and NIH criteria can be used for 
adolescent girls, this criterion often leads to over diagnosis because of the similarity in 
physiological changes during puberty and common PCOS symptoms (Drosdzol-Cop et. 
al., 2014). Although tightening of these current criteria was proposed, it has not yet been 
accepted (Drosdzol-Cop et. al., 2014, Rotterdam, 2007).  
Although polycystic ovaries can be defined by a transvaginal ultrasound (Balen, 
2003), polycystic ovaries are also a normal physiological variant of adolescents 
(Rosenfeld, 2011). Furthermore, only 40% of adolescent women with PCOS have 
polycystic ovaries on ultrasound; therefore the use of a transvaginal ultrasound in 
adolescents may not confirm PCOS (Venturol, Porcu, Fabbri, Paradisi, Ruggeri, Bolelli, 
1986). A study done by Barron (2004) recommended teaching adolescents how to 
distinguish an annovulatory cycle from an ovulatory cycle; this differentiation could aid 
practitioners in their diagnosis by teaching adolescents to differentiate the two.  
Recent recommendation by American Congress of Obstetricians and 
Gynecologists’ (ACOG, 2010) states girls as young as age 13 to 15 should begin annual 
reproductive health care visits in addition to their annual well-child visits. ACOG’s 
stance is by engaging teens early in discussions about pubertal development; 
obstetrician–gynecologist can supplement care given by the primary health care provider 
helping build a supportive physician–patient relationship as teens start learning to 
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negotiate the health care system on their own (ACOG, 2010). As infertility is a 
complication of PCOS with significant importance to adult women.  A study done by 
Upadhya and Trent (2007) assessed the impact infertility has on adolescents with PCOS. 
Although there were concerns about raising the issue with adolescents, mainly creating 
distress among adolescents who were not yet considering fertility. Upadhya & Trent 
(2007) found there were benefit to early reproductive care and ongoing discussion with 
girls diagnosed with PCOS. This was due to additional finding of this study that if 
adolescents perceive their fertility is diminished or impaired they were less likely to use 
oral contraception as a treatment for PCOS.  
Intervention and Treatment Options  
Lifestyle Modifications. Obesity in women alone should alert health care 
providers to consider diagnosis of PCOS (Glueck et al., 2005), because weight loss of 5-
10% BMI alone shows significant reversible effects of PCOS.  A structured lifestyle 
modification program should be first line treatment for weight loss of all overweight 
women with or without PCOS (Nieuwenhuis-Ruifrok, Kuchenbecker, Hoek, Middleton, 
&Norman, 2008). Lifestyle modification should include nutrition counseling as well as 
an exercise program. Nutrition counseling alone has demonstrated a decrease in weight 
gain and body fat as well as lowering insulin levels (Bruner, Chad, & Chzen, 2006). 
Decreasing body fat, especially within the abdomen may also improve metabolic and 
hormonal profiles even with only a minimal loss in overall body mass (Bruner et al., 
2006). 
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Pharmacological Treatment. Traditionally oral contraceptives were used to correct 
menstrual irregularities, hyperandrogenism, acne, and hirsutism. Currently Metformin is 
the treatment of choice. Metformin not only corrects menstrual irregularities and 
hyperandrogenism, but restores ovulation in 3/4 of women who take it, as well as 
improving insulin sensitivity of cells and glucose metabolism (Vandermolen, Ratts, 
Evans, Stovall, Kauma & Nestler, 2001). Additionally, effects of Metformin are even 
more pronounced in adolescents with PCOS (Salmi, Zisser & Jovanovic, 2004). 
Studies on PCOS in Adolescents  
Majority of studies conducted on PCOS have been quantitative with a focus on 
the disorder’s pathophysiolgy, symptoms, and treatments. A literature review done by 
Himelein and Thatcher (2006) revealed few studies addressed psychological concerns of 
PCOS. Combination of physical and clinical manifestations of PCOS, as well as timing 
of symptoms, coincides with a time where adolescents are undergoing identity 
development. There is a potential for great emotional distress with this syndrome 
(Himilein & Thatcher, 1006; Jones et al., 2008; Jones et al., 2011). Over the past decade, 
PCOS  research has increasingly examined the health-related quality of life (HRQL) of 
women with this syndrome to further understand effects PCOS has on those diagnosed 
(Himilein & Thatcher, 1006; Jones et al., 2008; Jones et al., 2011). 
 Weiss and Bulmer (2011) conducted a qualitative study to investigate emotional 
distress resulting from PCOS in adolescence.  Data was obtained through personal, semi-
structured interviews of 12 young women with PCOS from ages 18-23 at college 
campuses in New England. The study concluded the women faced numerous physical, 
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social, and emotional challenges on a daily basis. As the women came to terms with this 
chronic condition they realized there was a need for a more meaningful patient-provider 
relationship. Participants felt adolescents and young women in their early twenties could 
benefit from a comprehensive holistic treatment plan including useable information, 
psychosocial support, along with mechanisms on how to cope with symptoms.  
A retrospective study done by Bruni, Dei, Nannini, Balzi and Nuvolone (2010) 
evaluated correlations between PCOS, obesity, and metabolic risk factors in adolescents 
(ages 12-19). Researchers examined clinical charts and laboratory data of 250 adolescent 
females in the first 8 years of gynecological age at a pediatric and gynecology unit at the 
University of Florence. Negative correlation between weight gain and severity of PCOS 
symptoms was found. In fact weight gain is probably the key factor in modifying severity 
of symptoms in adolescents (Bruni et al., 2010). This study concluded an intervention on 
lifestyle ought to be a priority in the management of these patients to prevent metabolic 
consequences of PCOS. 
 Although lifestyle modifications encouraging dietary change and physical activity 
are standard treatments for obesity, it is clear with the rise of obesity in adolescence, 
nearly triple since 1980 there is a need for effective treatment plan (Ogden, Carroll, 
Curtin, Lamb, & Flegal, 2010).  A study done by Jakubowski, Black, Nokali, Belendiuk, 
Hannon, Arslanian, and Rofey (2012) looked at adolescent-parent relationships of forty 
adolescent females with PCOS participating in a weight management program. The 
stages of change model were used to assess readiness to change weight control behaviors. 
Participants, adolescents and parents, were given a questionnaire which assessed four 
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weight control domains. Their  finding that parent change from baseline to treatment 
completion significantly predicts adolescent change in BMI from baseline to treatment 
completion were consistent with previous evidence for the importance of parent 
involvement in and commitment to child weight management interventions (Jakubowski 
et al. 2012)..  Therefore, ffindings of this study supported the importance of parental 
involvement for youth’s ability to manage their weight (Jakubowski et al. 2012).  
 Trent, Austin, Rich, and Gordon’s (2005) cross-sectional study on 283 healthy 
and PCOS-affected adolescent girls evaluated effects of body mass index (BMI) on 
quality-of-life disturbances in adolescents with PCOS. Trent et al. (2005) found 
adolescent girls with PCOS have significant disruption in health related quality of life 
(HRQL) compared to their peers. Adolescents with PCOS scored lower on general health 
perceptions scale, physical functioning scale, family activities scale, and general behavior 
scale and scored higher on changes in health in the last year subscale. Trent et al. (2005) 
concluded clinical interventions effectively addressing weight issues in adolescence with 
PCOS may improve overall HRQL.  
Laitinen, Taponen, Martikainen, Pouta, Millwood, Hartikainen, Ruokonen, Sovio, 
McCarthy, Franks, and Ja¨rvelin (2003) conducted a longitudinal population-based study 
on a cohort of women born in 1966 to study association between body size from birth to 
adulthood and self-reported symptoms of PCOS, particularly hirsutism and menstrual 
disturbances. Out of 2007 subjects, 528 had self-reported symptoms of PCOS.  An 
increased risk of PCOS symptoms, hirsutism and menstrual abnormalities, had been 
observed in 30-41% of these women who were overweight, obese, or had abdominal 
obesity. Study results suggested obesity in adolescence, and weight gain after 
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adolescence particularly in the abdomen, are associated with self –reported PCOS 
symptoms in adulthood. 
Literature on PCOS demonstrates the negative impact of PCOS on quality of life and 
health status; and highlights the importance of early diagnosis for timely interventions. 
Adolescence is the phase where young women are undergoing identity development as 
well as a heightened sense of body image awareness. Cosmetic clinical manifestations of 
PCOS may affect social interactions and long-term emotional well-being (Weiss & 
Bulmer, 2011). Adolescents are at risk for reproductive, metabolic, and psychological 
consequences as a result of this common and reversible endocrine syndrome. However, 
there is a gap in the literature investigating the barriers of diagnosing PCOS in 
adolescents. Therefore the purposes of this study are to: (1) identify factors practitioners 
consider when determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) 
identify barriers to early diagnosis of PCOS in adolescents (ages 13-18) among 
practitioners.  
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Chapter 2: Theoretical Model 
The Theory of Planned Behavior Model 
The theory of planned behavior (TPB) is a prominent reasoned action model that 
has been used to understand, predict, and change human social behaviors (Ajzen, 2011). 
TPB suggests human behaviors are not mindless or uncurious acts rather conscious 
awareness of thoughts leading to the decision of actions. TPB postulates human behavior 
is guided by three main thought processes: what are the behavioral beliefs or likely 
consequences of a behavior; what are the normative beliefs or beliefs of others 
expectations of your behavior; and what factors or control beliefs cause or stop a 
behavior from being performed (Ajzen, 2011). TPB proposes these three thought 
processes are a pathway to three concepts of this theory: attitude, subjective norm, and 
behavioral control (Ajzen, 2011; Cortoos, Schreurs, Peetermans,De Witte & Laekeman, 
2012).  These three thought processes then lead to the formation of a behavioral intention 
(Ajzen, 2011). Intention is the immediate antecedent of behavior, as well as a function of 
attitude toward the behavior, subjective norm, and perceived behavioral control (Ajzen, 
2011) 
In respect to the TPB (see Figure 1), behavioral beliefs produce a favorable or 
unfavorable attitude toward the behavior. Attitude of behavior links positive or negative 
connotation to the behaviors outcome. Therefore, according to the TPB, attitude toward a 
behavior is determined by accessible behavioral beliefs, linking behaviors to various 
outcomes and attributes. Normative beliefs are the result of subjective norms, referring to 
perceived behaviors a person thinks another individual expects from them. It is assumed 
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subjective norms are determined by the amount of control perceived behaviors have over 
a person. Control beliefs lead to perceived behavioral control and are determined by the 
amount of control a person perceives they have over any given behavior. Intention is an 
indication of a person’s willingness to perform a behavior, and is based on attitude 
toward the behavior, subjective norm, and perceived behavioral control. Behavior, the 
observable response in a given situation, can then be predicted by actual behavioral 
control, perceived behavioral control, and intention.  In the TPB, behavior is a function of 
compatible intentions and perceptions of behavioral control (Ajzen, 2011).  
Figure 1  
Theory of Planned Behavior 
 
 
 
 As a general rule, the more favorable the attitude and subjective norm, the greater 
the perceived control, the stronger a person’s intention to perform the behavior in 
question should be. Implying only when a person has the 
control over the behavior will a favorable intention produce a favorable behavior. TPB 
assumes people have a great deal of control over their behavior, and are expected to carry 
out their intentions when the opportunity arises. Ho
difficult to elicit, one must also consider perceived behavioral control to help understand 
this in relation to intention. Perceived behavioral control can be substituted for actual 
control, also having the ability to pred
this theory can be seen in the diagram in Figure 2.
Figure 2 
Schematic Representation of Theory of Planned Behavior
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18 
 
There are a host of coorelational studies giving rise to empirical support for TPB 
(Ajzen, 1985, 1989, 1991, 2006, 2012; Cartoos et al., 2012; Deskins et al., 2006; 
Handbury, Wallace & Clark, 2010; Kelly et al., 2011; Gerend and Shepherd, 2012).  
These studies have repeatedly demonstrated the ability of TPB to predict intentions and 
behavior as well as interventions showing changes in behavioral, normative, and control 
beliefs can change intentions (Ajzen, 2011; Cartoos et al., 2012; Deskins et al., 2006; 
Handbury et.al., 2010; Kelly et al., 2011; Gerend and Shepherd, 2012).  The application 
of TPB in varied domains has allowed for identification of socially significant behavior 
through collection of information about behavioral, normative, and control related factors 
of many behaviors (Ajzen, 2011). This in turn provided the basis for effective 
interventions to modify social behaviors in a positive way. 
Handbury et.al., (2010) found the use of TPB effective in exploration of barriers 
health professional’s had to adhering to national suicide prevention guidelines as a way to 
create interventions to increase their adherence. Cartoos et al. (2012) found TPB to be 
effective in identifying barriers physician’s had in antibiotic guideline adherence to 
improve their prescribing practice of antibiotics. Deskins, Harris, Bradlyn, Cottrell, 
Coffman,  Olexa, and Neal (2006) used TPB to identify barriers West Virginians faced to 
participating in health screening so interventions could be put in place to improve 
participation. Kelly, Deane, Mc Carthy, and Crowe (2011) used TPB to predict intentions 
of clients who have underwent alcohol and drug detoxification to undergo subsequent 
treatment to avoid relapse. Gerend and Shepherd (2012) used the TPB to predict 
decisions of patients to obtain the human papillomavirus vaccination.  
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Theory of planned behavior was used to guide this descriptive study for the 
purpose of identifying barriers in diagnosing polycystic ovarian syndrome (PCOS) in 
adolescence among practitioners. TPB offers a useful model for understanding the 
decision making process an individual goes through to perform an action such as 
diagnosing. Although the TPB offers three main concepts to understand an individual’s 
intention to perform an action, only the attitude toward the behavior and the intention of 
the behavior will be explored in this study. 
In order to promote timely diagnosis of PCOS in adolescence for subsequent 
intervention, it is important to identify barriers practitioners have in diagnosing PCOS in 
adolescence. Techniques such as developing a questionnaire to assess barriers require 
support of a theory such as the TPB.  In this study, theoretical definition of barriers is 
anything preventing a practitioner from diagnosing PCOS in an adolescent who 
demonstrates symptoms of PCOS. Barriers will be measured by the questionnaire: 
Polycystic Ovarian Syndrome in Adolescents. TPB will aid in the assessment of barriers 
by thoroughly examining the habits and perceptions that exist in the diagnosis of PCOS 
by practitioners to address identified barriers. 
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Chapter 3: Methodology 
Design 
 This descriptive study seeks to identify barriers preventing practitioners from 
diagnosing Polycystic Ovarian Syndrome (PCOS) in adolescence.  
Subjects  
The researcher contacted the Ohio Medical Board and the Ohio Board of Nursing 
for email access to potential study participants. The researcher was directed to the Public 
Information Request Tracking (PIRT) team from Ohio’s Office of Information 
Technology Enterprise Computing which provides licensee data for the state of Ohio to 
the public through a computerized database. Inclusion criteria for this study were 
practitioners who provide women’s health care for adolescents ages 13 to 18 within the 
state of Ohio. The inclusion criterion for this study was used to generate key terms to 
screen through the database for potential participants.  Based on inclusion criterion, the 
researcher selected the potential participants: medical doctors, doctors of osteopath who 
specialize in the following: endocrinology, family practice, gynecology, obstetrics and 
gynecology, obstetrics, pediatrics, or pediatric endocrinology within the state of Ohio. All 
certified nurse practitioners, certified nurse midwives, and clinical nurse specialists in the 
state of Ohio were included regardless of their specialty area because they were not 
differentiated by category in the PIRT database. Participants identified their specialty 
when completing the study questionnaire (see Appendix A-Polycystic Ovarian Syndrome 
in Adolescents Questionnaire). A total of 16,274 practitioners were selected to participate 
in this study.  
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Measurement Tools 
Barriers to diagnose PCOS in adolescents were explored using the Polycystic 
Ovarian Syndrome in Adolescence questionnaire (PCOS questionnaire) (see Appendix). 
The PCOS questionnaire was developed by the researcher to explore the process of 
making the diagnosis of PCOS in adolescents, and to identify associated barriers of 
making the diagnosis among practitioners. This eighteen-item electronic questionnaire 
has seventeen close-ended multiple choice questions and one open-ended question. The 
questionnaire consists of three categories including demographic information, diagnostic 
process of PCOS, and perceived barriers in diagnosing PCOS in adolescents. Estimated 
length of time for completing the questionnaire was 2-5 minutes.  
 Face validity and panel of expert validity were established.  The panel consists of 
four experts: (1) a pediatric clinical specialist (2) a certified nurse practitioner in 
reproductive medicine, who has been working with women to overcome the effects of 
PCOS in fertility management, (3) an academic expert on PCOS, and (4) a family nurse 
practitioner who has done a significant amount of work in women’s health and has seen 
firsthand the effects of PCOS in women. The questionnaire was revised based on 
feedback from the panel then resubmitted to the panel for final review.  
Procedure for Data Collection  
 A sample of 16,274 practitioners who met the inclusion criteria for this study 
were invited to participate. Participants received an informational cover sheet with the 
PCOS questionnaire via email.  The information sheet provided study details and 
explained consent to participate was implied by completing the PCOS questionnaire (see 
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Appendix B: Information Sheet).  Participants completed the PCOS questionnaire online 
via a link through Qualtrics Survey Program.   
Internet survey methods are a convenient, cost-effective way to recruit 
participants. However, low response rates of less than 20% have been reported in the 
literature (Hunter, Corcoran, Leeder, and Phelps, 2012; Kongsved, Basnov, Holm, and 
Hjoullund, 2007). To increase participation for this study, the following tactics were 
employed. The researcher sent the email out to participants on July 29, 2014. Two email 
reminders were sent to the participants after the initial email; a week after the email was 
sent, and the 3 days prior to the completion deadline.  A completion deadline of August 
11, 2014 was clearly specified in the email. An extension of the survey was given from 
August 14, 2014 to August 17, 2014 in attempt to attain more study participants. An 
appreciation email was sent to the participants upon completion of the questionnaire 
provided via the Qualtric’s Survey Program. Participants will receive the survey results 
via email as soon as data analysis is completed (Hunter, Corcoran, Leeder, and Phelps, 
2012). Data analysis was conducted immediately following the data collection.   
Data Analysis   
 Descriptive statistics (means, standard deviations, percentages, and range) was 
conducted to describe the diagnostic process and barriers identified in determining the 
diagnosis of PCOS. Data analysis was conducted using PSPP. The alpha was set at the 
0.05 level. 
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Ethical Considerations 
 Study approval was attained from the Cedarville University Internal Review 
Board (IRB). This study was “exempt”. Completion of the questionnaire was treated as 
consent to participate. No harm occurred to participants of this study.   
Strengths and Weaknesses 
There are several strengths for this study. This descriptive study addresses gaps in 
the literature by exploring potential barriers of the PCOS diagnosis in adolescents.  
Results of this study will provide a foundation for the early intervention of adolescents 
with PCOS by raising awareness of the need to establish early diagnosis of PCOS in 
adolescents when clinical manifestations appear.  In addition, participants of this study 
were selected from a database which included all licensee data for the state of Ohio, 
providing a large framework to an accessible population.  The comprehensive database 
also provided the potential to increase external validity of the study findings.  Lastly, 
Quatric Survey Software facilitates immediacy of Internet survey results, storage and 
analysis of the data, and ultimately reduced errors in data entry.  While low response rate 
from email and Internet surveys have historically been reported in the literature (Hunter 
et al., 2012; Kongsved, Basnov, Holm & Hjollund 2007), measures were taken to 
increase study participation rates.  Measures included: using a shorter questionnaire, 
providing a clear completion deadline, sending two reminder emails, and providing 
survey results.   
Two major weaknesses are present for this study.  The PCOS questionnaire was 
developed by the researcher.  While face validity and panel of expert validity were 
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established, further work is needed to establish the psychometric properties, such as 
validity, reliability, and sensitivity to change.   In addition, recruitment bias of individuals 
who favor electronic surveys may exist. Therefore, under-recruitment of individuals who 
do not favor electronic surveys may impact generalizability of study results.   
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Chapter 4: Results 
There is a gap in the literature investigating the barriers of diagnosing PCOS in 
adolescents. Therefore the purposes of this study are to: (1) identify factors practitioners 
consider when determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) 
identify barriers to early diagnosis of PCOS in adolescents (ages 13-18) among 
practitioners. An electronic survey was sent to 16,274 participants via the Qualtrics 
Survey Program in August 2014. A total of n=341 completed and returned the survey. 
The overall response rate was 2.09%. 
Demographic Characteristics 
Demographic characteristics are presented in Table 1. Of the 341 participants, 
most were females (86%, n= 294), between the ages of 56- 65 (30%, n=103), white or 
non-Hispanic (94%, n= 317), certified nurse practitioners (62%, n=211).  Practice 
specialties include family practice (28%, n=96), obstetric gynecologist (21%, n=72), and 
pediatric endocrinologists (1%, n=5) (see Table 1.2).  Twenty-one percent (n=72) of the 
participants have been working within their practice setting for more than 20 years, while 
34% (n=116) have only been working within their practice setting for 5 years or less.  
Polycystic Ovarian Syndrome Diagnosis (PCOS) in Adolescents 
The majority of the participants (n=163; with a yield of 34%, n=115 for missing 
data) have diagnosed an adolescent (age 13-18) with PCOS in their practice setting. 
Pediatrics 100%, (n=26), pediatric endocrinology 100% (n=5), gynecology 93% (n=13), 
obstetric gynecology 80% (n=53), and family practice 60% (n=43) are among the top 
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practice specialties diagnosing adolescents in ranking order.  Seventy-two percent 
(n=243) of the responses indicated the prevalence of PCOS among adolescents within 
participants practice setting to be less than 10%. The majority of the adolescents 
diagnosed were between the ages of 16-18 (73%, n=116).  
The most frequently reported clinical manifestations were menstrual disruptions/ 
irregularities (99%, n=161), acne (91%, n=149), hirsutism (90%, n=147), and obesity 
(83%, n=136), which were also symptoms most often used by participants to diagnose 
PCOS in adolescents.  Sixty participants (18%) used at least three out of the four 
symptoms (oligo-amenorrhea, anovulation, clinical signs of hyperandrogenism, and 
biochemical signs of hyperandrogenism) to make their diagnosis, while forty-one 
participants (12%) used polycystic ovaries to make their diagnosis. The NIH diagnostic 
criteria guided 52% (n=152) of the participants in diagnosing adolescents. Thirty-seven 
participants (11%) used both NIH and Rotterdam ESHRSA/ASRM criteria to aid in the 
diagnosis of PCOS among adolescents (see Table 2). Other tools/testing such as diabetic 
screening (67%, n=212), androgen analysis (66%, n=207), and menstrual calendars (62%, 
n=196) were also used. Over half of the participants (52%, n=171) admit to diagnosing 
adult women who reported clinical manifestations in their adolescent years. Data 
regarding diagnosing PCOS in adolescents is presented in Table 3. 
Barriers to diagnosing Polycystic Ovarian Syndrome Diagnosis (PCOS) in 
Adolescents 
More than half of the participants (56%, n=182) perceived barriers exist in 
diagnosing the adolescent population (see Table 5). The main barriers identified were: 
27 
 
adolescents were not seeking fertility counseling (44%, n=134), no definitive diagnostic 
criteria to diagnose adolescents (20%, n=63), lack of knowledge regarding diagnosis and 
treatment (18%, n=56) therefore participants were not diagnosing PCOS in the 
adolescent. Participants also identified PCOS manifestations as a part of the normal 
physiologic pubertal changes and will subside (18%, n=55), and not recognizing PCOS in 
adolescents (16%, n=49) as barriers.  
 Participants listed several “other” barriers to the diagnosis of PCOS in 
adolescents. Common themes included infrequent visits to healthcare providers (14%, 
n=19), limited access to the healthcare system (.01%, n=1), and adolescent’s reluctance 
to come into the office (4%, n=5). If adolescents were not sexually active they may not 
present for an evaluation at all (4%, n=6). In addition parent’s denial of the potential 
PCOS diagnosis (10%, n=12), exhaustion on behalf of the parent and the adolescent from 
multiple tests prior to the confirmation of the PCOS diagnosis (4%, n=6), as well as 
parent’s and adolescents overlooking PCOS symptoms and perceiving them as a normal 
part of adolescence (10%, n=15). Data regarding barriers are presented Table 6. 
Table 1 
Demographic Characteristics  
Variables                                                                     n                                              %                                                                
 
Gender        
Male        47             14% 
Female     290             86% 
Age (years) 
 25-35                                                                68             20% 
 36-45        71             21% 
 46-55        78             23% 
 56-65      101             30% 
   66+        18    5% 
28 
 
Table 1 
Demographic Characteristics (con’t) 
Variables                                                                       n                                           % 
 
Ethnicity 
 White or non-Hispanic   314             94% 
 Black or African American                  7    2% 
 American Indian or Alaska Native      1               0% 
 Asian          4    1% 
Native Hawaiian, or other Pacific Islander     1    0%  
Hispanic         5    1%  
Other          3    1% 
Practitioner Type 
 Medical Doctor      63             19% 
 Doctor of Osteopath      13              4% 
 Certified Nurse Practitioner              210             63% 
 Certified Nurse Midwife     15    4% 
 Clinical Nurse Specialist     25    7% 
 Other Non-Physician Provider      8    2% 
Practice Specialty 
Endocrinology        5               1% 
Family Practice      96             28% 
 Gynecology       14    4% 
Obstetrics and Gynecology     71             21% 
Obstetrics         0    0% 
Pediatrics       36             11% 
Pediatric Endocrinology        5    1% 
Women’s health center       5    1% 
Other       105             31% 
Years worked in practice setting    
0-5      116             35% 
 6-10        62             18% 
 11-15        53             16% 
 16-20        34             10% 
 20+        71             21% 
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Table 2  
Diagnosis of PCOS within Specialty Practice 
 
Have diagnosed an adolescent (age 13-18) 
with PCOS 
n % 
Practice specialty: Endocrinology 2 1% 
Family Practice 43 26% 
Gynecology 13 8% 
Obstetrics and 
Gynecology 53 33% 
Pediatrics 26 16% 
Pediatric Endocrinology 5 3% 
Women's health center 3 2% 
Other 18 11% 
Total 163  
 
Table 3 
PCOS Diagnosis in Adolescents 
Variables                                                                     n                                             % 
         
Estimation of prevalence of PCOS in practice 
 1-5%      133             40% 
 5-10%      108             32% 
 10-20%       48             14% 
 20-30%         7    2% 
 >30%          5    2% 
 None        32             10%  
Estimation of prevalence of PCOS among 
 adolescents (ages 13-18) in practice 
 1-5%      140             42% 
 5-10%        99             30% 
 10-20%       23               7%  
 20-30%         6               2%  
 >30%          2               1% 
 None        62             19% 
Have you diagnosed a patient with PCOS 
 Yes      222             66%  
 No      115             34%  
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Table 3 
PCOS Diagnosis in Adolescents (con’t) 
Variables                                                                     n                                             % 
         
Have you diagnosed an adolescent (ages 13-18)  
 with PCOS 
 Yes      162             73% 
 No        61             27% 
Age range of diagnosed adolescent (ages 13-18)  
 with PCOS 
 <13        11               7% 
 13-15        33             21% 
 16-18      115             72% 
 Other <13       11               7% 
Clinical manifestations seen in adolescents  
diagnosed with PCOS 
Hirsutism     146             90% 
Acne      148             91% 
Overweight (BMI 25.0-29.9/ 85-95th   118             73% 
percent.) 
Obesity (BMI 30.0+/95th percentile)  135             83% 
Insulin Resistance    100             62% 
Menstrual disruption/irregularities  160             99% 
Other        17             10% 
Symptoms most often used to diagnose PCOS in 
 adolescents 
Oligo-amenorrhea    134             83% 
 Anovulation       85             52% 
Clinical signs of hyperandrogenism   159             98% 
Biochemical signs of hyperandrogenism  123             76% 
Polycystic Ovaries       41             25% 
Other          3                2%  
Diagnostic criteria used in diagnosing PCOS 
 in adolescents 
 NIH      148             52% 
 Rotterdam EHRE/ASRM     89             31% 
 Other        93             33% 
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Table 3  
PCOS Diagnosis in Adolescents (con’t) 
Variables                                                                       n                                           % 
 
Tool(s)/testing used to diagnose PCOS in adolescents 
Menstrual Calendar    193             62% 
Androgen Analysis    204             65% 
Diabetic Screening    208             67% 
Diagnostic Imaging    124             40% 
Other        63             20% 
I have diagnosed adult women with PCOS  
who reported clinical manifestations  
in adolescent years (ages 13-18) 
 Yes      167             51% 
 No      160             49% 
  
Table 4 
Barriers to Diagnosing Polycystic Ovarian Syndrome (PCOS) in Adolescents  
Variables                                                                      n                                            % 
 
Do you perceive barriers in diagnosing  
 PCOS in adolescents 
 Yes      179             55% 
 No      144             45% 
 Missing Data       14               4% 
What barrier(s) do you encounter when 
 diagnosing adolescents with PCOS 
I have not seen PCOS in adolescents    49             16% 
No defined diagnostic criteria     61             20% 
Manifestations also part of normal    
physiologic pubertal changes      56             18% 
Adolescents are not seeking fertility 
Counseling     131             43% 
 Lack of knowledge concerning    
the diagnosis and treatment of PCOS    55             18% 
Other       133             44% 
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 Table 5 
 Practice specialty: Barriers to diagnosing PCOS in adolescent population 
 
Do you perceive any barriers 
to diagnosing PCOS in the 
adolescent population? 
Total Yes No 
Practice 
specialty: 
Endocrinology 3 2 5 
Family Practice 58 37 95 
Gynecology 6 9 15 
Obstetrics and 
Gynecology 35 34 69 
Pediatrics 23 11 34 
Pediatric 
Endocrinology 3 2 5 
Women's health center 5 0 5 
Other 49 50 99 
Total 182 145 327 
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Chapter 5: Discussion 
Comparison with the Current Literature  
 Results of study identified factors considered and barriers experienced when 
practitioners diagnose PCOS in adolescents. In this study 72% of participants estimated 
prevalence of PCOS in the adolescent population being less than 10%. In addition 
diagnosis of PCOS in adolescent was made across the following practice specialties: 
endocrinology, family practice, gynecology, obstetrics and gynecology, pediatrics, 
pediatric endocrinology, women’s health center. Family practice specialists (19%, n=43), 
and pediatricians (6%, n=26) that diagnose PCOS in adolescents (age 13-18) should also 
be noted. These findings demonstrate that PCOS is not exclusively being diagnosed while 
women are in their reproductive years, which is consistent with current literature 
(Makarov, 2011; Meurer, Kroll, & Jamieson, 2006).  
Diagnosis of PCOS. Currently PCOS in adolescents is diagnosed using criteria for 
the adult population (Bates & Legro, 2012; Drosdzol-Cop et. al., 2014; Glueck, et al., 
2005; Nicholson, et al., 2010). The two diagnostic criteria used are the Revised 2003 
Rotterdam ESHRE/ASRM consensus criteria (Rotterdam, 2004) in which two of the 
three are required for diagnosis: oligo-amenorrhea or anovulation, clinical or biochemical 
signs of hyperandrogenism, or polycystic ovaries. National Institute of Health’s (NIH) 
consensus criteria(1990) is based on symptoms of chronic anovulation, clinical or 
biochemical signs of hyperandrogenism; while excluding all other etiologies (Glueck, et 
al., 2005; Nicholson, et al., 2010; West, et al., 2014). Participants of this study 
acknowledged there were no diagnostic guidelines/criteria for adolescents with PCOS 
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(20%, n=63). Thirty-seven participants (11%) used both NIH and Rotterdam 
ESHRSA/ASRM criteria to aid in diagnosis of PCOS among adolescents.  
Current there are no diagnostic guidelines for adolescents with PCOS (Drosdzol-Cop 
et. al., 2014; Golden and Carlson 2010; Weiss and Bulmer 2010). Therefore, basis of 
diagnosis is on hyperandrogenism, oligo-amenorrhea or anovulation, and polycystic 
ovaries (West, et al., 2014). This could account for the low number of pediatricians (6%, 
n=26) found in this study diagnosing PCOS in adolescents (age 13-18).  Study findings 
show this current practice for making diagnosis of PCOS in adolescents. Sixty 
participants (18%) used at least three out of four symptoms (oligo-amenorrhea, 
anovulation, clinical signs of hyperandrogenism, and biochemical signs of 
hyperandrogenism) to make their diagnosis, while forty-one participants (12%) used 
polycystic ovaries to make their diagnosis. Due to lack of diagnostic guidelines, diagnosis 
is often problematic because symptoms commonly experienced by girls in their teenage 
years, such as irregular menses, acne, and weight gain are also part of normal physiologic 
pubertal changes (Hassan & Gordon, 2007; West, et al., 2014). For this age group, the 
most robust diagnostic criterion for PCOS is clinical or biological expression of 
hyperandrogenism (Drosdzol-Cop et. al., 2014; Hassan & Gordon, 2007; West, et al., 
2014).   
Since PCOS is a diagnosis of exclusion tools/test are often used to aid in diagnosis of 
PCOS (Glueck, et al., 2005; Nicholson, et al., 2010).  Diabetic screening is important due 
to the correlation of and metabolic consequences of hyperinsulinemia in PCOS; insulin 
resistance, impaired glucose tolerance, and type 2 diabetes mellitus (Stankiewicz & 
Norman, 2006). Androgen analysis can help rule out other causes of hyperandrogenism 
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ruling out an androgen-secreting tumor, congenital adrenal hyperplasia, or Cushing’s 
stigmata (Stankiewicz & Norman, 2006). Menstrual calendars can help distinguish 
oligomenorrhea and anovulation (Hart, 2007; Makarov, 2011; Meurer, Kroll, & 
Jamieson, 2006; West, et al., 2014).  This study shows participants are using tools/testing 
such as diabetic screening (67%, n=212), androgen analysis (66%, n=207), and menstrual 
calendars (62%, n=196) to further aid in diagnosis.  
Barriers. Over half of participants (52%, n=171) report diagnosing adult women who 
reported clinical manifestations in their adolescent years. Potential reasons may include: 
(1) parent’s denial of potential PCOS diagnosis (10%, n=12), (2) exhaustion on behalf of 
the parent and adolescent from multiple tests were prior to confirmation of PCOS 
diagnosis (4%, n=6), and (3) parents and adolescents overlooking symptoms of PCOS 
perceiving them as a normal part of adolescence (10%, n=15). Jakubowski, et al., (2012) 
investigated adolescent-parent relationships of forty adolescent females with PCOS who 
were participating in a weight management program. Their  finding that parent change 
from baseline to treatment completion significantly predicts adolescent change in BMI 
from baseline to treatment completion were consistent with previous evidence for 
importance of parent involvement in and commitment to child weight management 
interventions (Jakubowski et al. 2012)..  Therefore, findings of this study support 
importance of parental involvement for youth’s ability to manage their weight 
(Jakubowski et al. 2012).  
Study participants recognized several “other” barriers to diagnosis of PCOS in 
adolescents worth mentioning. Common themes included infrequent visits to healthcare 
providers (14%, n=19), limited access to healthcare system (.01%, n=1), and adolescent’s 
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reluctance to come into the office (4%, n=5). This study found if adolescents were not 
sexually active they may not present for an evaluation at all (4%, n=6). This further 
supports American Congress of Obstetricians and Gynecologists’ (ACOG, 2010) stance 
for adolescent girls to have reproductive health care visits in addition to annual well-child 
visits, as many of those suffering from PCOS are not being seen by a healthcare provider. 
As infertility is a complication of PCOS with significant importance to adult women.  A 
study done by Upadhya and Trent (2007) assessed impact infertility has on adolescents 
with PCOS. Although there were concerns about raising the issues of infertility with 
adolescents, mainly creating distress among adolescents who were not yet considering 
fertility. Upadhya & Trent (2007) also found that there were benefits to early 
reproductive care and ongoing discussion with girls diagnosed with PCOS. Additionally 
Upadhya & Trent (2007) found if adolescents perceive their fertility is diminished or 
impaired they were less likely to use oral contraception as a treatment for PCOS.  
Strengths 
There are several strengths for this study. This descriptive study addresses gaps in 
the literature by exploring potential barriers of PCOS diagnosis in adolescents.  Results 
will raise awareness of a need to establish an early diagnosis of PCOS in adolescents 
when clinical manifestations appear. In addition, potential participants of this study were 
identified from a comprehensive database for the State of Ohio, which provided a large 
framework of accessible population. These potential participants were medical doctors, 
doctors of osteopath, certified nurse practitioners, certified nurse midwives, and clinical 
nurse specialists. However, due to the nature of a convenience sample, electronic survey 
and low response rate, participants in this study may not represent the target population.  
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Lastly, Quatric Survey Software facilitates immediacy of Internet survey results, storage 
and analysis of data, and ultimately reduced errors in data entry.   
Limitations 
 Several threats to internal and external validity in this study were identified. The 
PCOS questionnaire was developed by the researcher and need further study to establish 
validity and reliability.  Some items on the survey may need to be revised in order to 
collect the highest level of data possible (e.g. ages, years of work experience). Low 
response rate (2.09%, n=341) threatened external validity and limited the generalizability 
of the findings. While low response rate from electronic mail and Internet surveys have 
historically been reported in the literature (Hunter et al., 2012; Kongsved, Basnov, Holm 
& Hjollund 2007), measures were taken to increase study participation rates.  These 
measures include: using a shorter questionnaire, providing a clear completion deadline, 
sending two reminder emails, and providing survey results. Findings of this study should 
not be generalized to all primary care providers as most of participants were certified 
nurse practitioners. 
Conclusion 
This study identified factors considered and barriers experienced when practitioners 
diagnose PCOS in adolescents. Practitioners are strongly encouraged to evaluate 
adolescents when clinical manifestations of PCOS occur. While some symptoms may 
appear to be a normal physiological part of puberty, diagnosis of PCOS should be 
considered. In addition, PCOS is a diagnosis of exclusion. Therefore parents should be 
encouraged to be patient and understanding with the diagnostic process of PCOS in their 
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adolescent since it can be time consuming. Future studies should focus on evaluating 
currently used diagnostic criteria in the adolescent population, and explore developing a 
specific diagnostic criterion for adolescents to increase diagnostic rates.  
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Appendix A 
Questionnaire: Polycystic Ovarian Syndrome (PCOS) in Adolescence  
Purpose: The purposes of this survey are to: (1) identify factors practitioners consider 
when determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) identify 
barriers to early diagnosis of PCOS in adolescents (ages 13-18) among practitioners. 
Instructions: Please choose the most appropriate response to the question. If more than one 
choice applies then choose all that apply. For the questions which require a written response, 
please provide a response to the best of your knowledge. 
Demographics 
1. Gender: 
a. Male 
b. Female 
2. Age: 
a. 25-35 
b. 36-45 
c. 46-55 
d. 56-65 
e. 66+ 
3. Ethnicity: 
a. White or non Hispanic 
b. Black or African American 
c. American Indian or Alaska Native 
d. Asian 
e. Native Hawaiian or Other Pacific Islander 
f. Hispanic 
g. Other  
4. Practice Area: 
a. Medical Doctors 
b. Doctors of Osteopath 
c. Certified Nurse Practitioners 
d. Certified Nurse Midwives 
e. Clinical Nurse Specialist 
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f. Other non-physician provider  
 
5. Practice specialty:  
a. Endocrinology 
b. Family Practice 
c. Gynecology 
d. Obstetrics and Gynecology 
e. Obstetrics 
f. Pediatrics 
g. Pediatric Endocrinology  
h. Women’s health center 
i. Other  
6. How many years have you been working in your practice setting? 
a. 0-5 
b. 6-10 
c. 11-15 
d. 16-20 
e. 20+ 
Polycystic Ovarian Syndrome Diagnosis (PCOS) in Adolescents 
7. Have you ever diagnosed a patient with PCOS? 
a. Yes 
b. No (if no, stop now and return survey) 
8. What is your estimation of the prevalence of  PCOS in your practice. 
a. 1-5% 
b. 5-10% 
c. 10-20% 
d. 20-30% 
e. > 30% 
9. What is your estimation of the prevalence of PCOS among adolescents (ages 13-18) in 
your practice.  
a. 1-5% 
b. 5-10% 
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c. 10-20% 
d. 20-30% 
e. > 30% 
10. I have diagnosed an adolescent (age 13-18) with PCOS.  
a. Yes 
b. No (if not skip question 11and 13) 
11. I have diagnosed PCOS in an  adolescent within the following age ranges: 
a. <13; if so at what age   
b. 13-15 
c. 16-18 
12. The clinical manifestation(s) I have seen in adolescents I have diagnosed with PCOS: 
(select all that apply) 
a. Hirsutism 
b. Acne 
c. Overweight (BMI 25.0-29.9/ 85th -95th percentile) 
d. Obesity (BMI 30.0+/95th percentile +) 
e. Insulin Resistance 
f. Menstrual disruption/irregularities 
g. Other 
13. The symptoms I most often use to diagnose PCOS in adolescents: (select all that apply) 
a. Oligo-amenorrhea 
b. Anovualtion 
c. Clinical signs of hyperandrogenism (excess hair growth, acne, alopecia, rapid 
weight gain/ difficulty losing weight) 
d. Biochemical signs of hyperandrogenism (hyperinsulinemia, hyperglycemia, 
hyperandrgenemia, dyslipidemia, elevated FSH:LH ratio) 
e. Polycystic Ovaries (ovarian volume > 10 ml “string of pearls”/ hyperthecotic 
appearance) 
f. Other   
14. Diagnostic Criteria I use to guide my diagnosis of PCOS in adolescents (select all that 
apply) 
a. NIH 
b. Rotterdam ESHRE/ASRM 
c. Other  
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15. The diagnosis of PCOS is typically made by exclusion. The tool(s)/testing that I use to 
diagnose PCOS in adolescents is/are: (select all that apply) 
a. Menstrual Calendar 
b. Androgen Analysis 
c. Diabetic Screening 
d. Diagnostic Imaging 
e. Other  
16. I have diagnosed adult women with PCOS who have reported clinical manifestations in 
adolescent years (ages 13-18) 
a. Yes  
b. No 
Barriers 
17. Do you perceive any barriers to diagnosing PCOS in the adolescent population? 
a. Yes 
b. No 
18. What barrier(s) do you feel you encounter when diagnosing adolescents with PCOS: 
(select all that apply) 
a. I have not seen PCOS in adolescents 
b. There is no defined diagnostic criteria to diagnose adolescents with PCOS 
c. The manifestations most often used to diagnose PCOS are  also part of normal 
physiologic pubertal changes and will subside 
d. Adolescents are not seeking fertility counseling 
e. My lack of knowledge concerning the diagnosis and treatment of PCOS 
f. Other barriers  
19. Please feel free to add any comments or suggestions to diagnostic barriers of PCOS in 
adolescence: 
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Appendix B 
Participants Information Sheet 
Dear Potential Participant’s, 
My name is Tara Williams I am a Registered Nurse currently working on my Masters 
Degree to become a Family Nurse Practitioner at Cedarville University. As a part of my 
capstone experience I am working on a research project titled “A Practitioner’s Perspective on the 
Barriers to Diagnosing Polycystic Ovarian Syndrome in Adolescents: A Descriptive Study”.  
Although the majority of reproductive and metabolic consequences can be identified in 
adolescence, diagnosis of PCOS for subsequent early intervention is still not taking place 
as many women are not being diagnosed until their reproductive years often after seeking 
the cause of their infertility. No literature could be found on barriers that contribute to the 
failure of early diagnosis of PCOS in adolescence. There is a gap in the literature 
investigating the barriers of diagnosing PCOS in adolescents.  
 I have selected you to help better understand the (1) factors practitioners consider when 
determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) barriers to early 
diagnosis of PCOS in adolescents (ages 13-18) among practitioners. This descriptive 
study is being conducted with the hope of addressing gaps in the literature by exploring 
the potential barriers of the PCOS diagnosis in adolescents.  Results of this study will 
provide a foundation for the early intervention of adolescents with PCOS through raising 
awareness of the need to establish an early diagnosis of PCOS in adolescents when the 
clinical manifestations appear. 
 I ask that you complete a short multiple choice questionnaire that can be accessed via the 
link provided at the bottom of this email. This questionnaire is based on the research findings 
in the literature. This eighteen-item electronic questionnaire consists of three categories: 
demographics, diagnostic process of PCOS and the perceived barriers in diagnosing PCOS in 
adolescents. The typical length of time for completing the questionnaire is 5-10 minutes. 
Completion of the questionnaire is treated as the consent to participate in this descriptive 
study. The survey results will be provided via email to participants.  
Thank you for your time and consideration, 
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Tara Williams 
Please follow the link provided below to the attached questionnaire- Polycystic Ovarian 
Syndrome in Adolescent Questionnaire and provide your feedback via email by August 11, 2014.  
Your assistance is greatly appreciated.  
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Appendix C 
Participants Information Sheet 
Please consider completing the PCOS Survey. Your time and knowledge in this matter 
will be greatly appreciated! Deadline for completion is a week away, August 11, 2014.  
Dear Potential Participants, 
My name is Tara Williams I am a Registered Nurse currently working on my Masters 
Degree to become a Family Nurse Practitioner at Cedarville University. As a part of my 
capstone experience I am working on a research project titled “A Practitioner’s Perspective on the 
Barriers to Diagnosing Polycystic Ovarian Syndrome in Adolescents: A Descriptive Study”.  
Although the majority of reproductive and metabolic consequences can be identified in 
adolescence, diagnosis of PCOS for subsequent early intervention is still not taking place 
as many women are not being diagnosed until their reproductive years often after seeking 
the cause of their infertility. No literature could be found on barriers that contribute to the 
failure of early diagnosis of PCOS in adolescence. There is a gap in the literature 
investigating the barriers of diagnosing PCOS in adolescents.  
 I have selected you to help better understand the (1) factors practitioners consider when 
determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) barriers to early 
diagnosis of PCOS in adolescents (ages 13-18) among practitioners. This descriptive 
study is being conducted with the hope of addressing gaps in the literature by exploring 
the potential barriers of the PCOS diagnosis in adolescents.  Results of this study will 
provide a foundation for the early intervention of adolescents with PCOS through raising 
awareness of the need to establish an early diagnosis of PCOS in adolescents when the 
clinical manifestations appear. 
 I ask that you complete a short multiple choice questionnaire that can be accessed via the 
link provided at the bottom of this email. This questionnaire is based on the research findings 
in the literature. This eighteen-item electronic questionnaire consists of three categories: 
demographics, diagnostic process of PCOS and the perceived barriers in diagnosing PCOS in 
adolescents. The typical length of time for completing the questionnaire is 5-10 minutes. 
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Completion of the questionnaire is treated as the consent to participate in this descriptive 
study. The survey results will be provided via email to participants.  
Thank you for your time and consideration, 
Tara Williams 
Please follow the link provided below to the attached questionnaire- Polycystic Ovarian 
Syndrome in Adolescent Questionnaire and provide your feedback via email by August 11, 2014.  
Your assistance is greatly appreciated.  
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Appendix D 
Participants Information Sheet 
Please consider completing the PCOS Survey. Your time and knowledge in this matter 
will be greatly appreciated! Deadline for completion is only 3 days away, August 11, 
2014.  
Dear Potential Participants, 
My name is Tara Williams I am a Registered Nurse currently working on my Masters 
Degree to become a Family Nurse Practitioner at Cedarville University. As a part of my 
capstone experience I am working on a research project titled “A Practitioner’s Perspective on the 
Barriers to Diagnosing Polycystic Ovarian Syndrome in Adolescents: A Descriptive Study”.  
Although the majority of reproductive and metabolic consequences can be identified in 
adolescence, diagnosis of PCOS for subsequent early intervention is still not taking place 
as many women are not being diagnosed until their reproductive years often after seeking 
the cause of their infertility. No literature could be found on barriers that contribute to the 
failure of early diagnosis of PCOS in adolescence. There is a gap in the literature 
investigating the barriers of diagnosing PCOS in adolescents.  
 I have selected you to help better understand the (1) factors practitioners consider when 
determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) barriers to early 
diagnosis of PCOS in adolescents (ages 13-18) among practitioners. This descriptive 
study is being conducted with the hope of addressing gaps in the literature by exploring 
the potential barriers of the PCOS diagnosis in adolescents.  Results of this study will 
provide a foundation for the early intervention of adolescents with PCOS through raising 
awareness of the need to establish an early diagnosis of PCOS in adolescents when the 
clinical manifestations appear. 
 I ask that you complete a short multiple choice questionnaire that can be accessed via the 
link provided at the bottom of this email. This questionnaire is based on the research findings 
in the literature. This eighteen-item electronic questionnaire consists of three categories: 
demographics, diagnostic process of PCOS and the perceived barriers in diagnosing PCOS in 
adolescents. The typical length of time for completing the questionnaire is 5-10 minutes. 
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Completion of the questionnaire is treated as the consent to participate in this descriptive 
study. The survey results will be provided via email to participants.  
Thank you for your time and consideration, 
Tara Williams 
Please follow the link provided below to the attached questionnaire- Polycystic Ovarian 
Syndrome in Adolescent Questionnaire and provide your feedback via email by August 11, 2014.  
Your assistance is greatly appreciated.  
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Appendix E 
Participants Information Sheet 
I had a very low response and am resending in hopes of gaining more participation for the 
sake of my research. Please reconseider responding to my survey by August 17,2014. If 
you have already responded please disregard and thank you for your input. 
If you have any questions or concerns please feel free to contact me at 
@cedarville.edu 
 
Dear Potential Participant’s, 
My name is Tara Williams I am a Registered Nurse currently working on my Masters 
Degree to become a Family Nurse Practitioner at Cedarville University. As a part of my 
capstone experience I am working on a research project titled “A Practitioner’s Perspective on the 
Barriers to Diagnosing Polycystic Ovarian Syndrome in Adolescents: A Descriptive Study”.  
Although the majority of reproductive and metabolic consequences can be identified in 
adolescence, diagnosis of PCOS for subsequent early intervention is still not taking place 
as many women are not being diagnosed until their reproductive years often after seeking 
the cause of their infertility. No literature could be found on barriers that contribute to the 
failure of early diagnosis of PCOS in adolescence. There is a gap in the literature 
investigating the barriers of diagnosing PCOS in adolescents.  
 I have selected you to help better understand the (1) factors practitioners consider when 
determining the diagnosis of PCOS in adolescents (ages 13-18) and (2) barriers to early 
diagnosis of PCOS in adolescents (ages 13-18) among practitioners. This descriptive 
study is being conducted with the hope of addressing gaps in the literature by exploring 
the potential barriers of the PCOS diagnosis in adolescents.  Results of this study will 
provide a foundation for the early intervention of adolescents with PCOS through raising 
awareness of the need to establish an early diagnosis of PCOS in adolescents when the 
clinical manifestations appear. 
 I ask that you complete a short multiple choice questionnaire that can be accessed via the 
link provided at the bottom of this email. This questionnaire is based on the research findings 
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in the literature. This eighteen-item electronic questionnaire consists of three categories: 
demographics, diagnostic process of PCOS and the perceived barriers in diagnosing PCOS in 
adolescents. The typical length of time for completing the questionnaire is 5-10 minutes. 
Completion of the questionnaire is treated as the consent to participate in this descriptive 
study. The survey results will be provided via email to participants.  
Thank you for your time and consideration, 
Tara Williams 
Please follow the link provided below to the attached questionnaire- Polycystic Ovarian 
Syndrome in Adolescent Questionnaire and provide your feedback via email by August 17, 2014.  
Your assistance is greatly appreciated.  
 
 
 
 
 
